Givaudan Wins Innovation Award for Lifenol at Vitafoods Europe 2025

Givaudan has been honored with an Innovation Award at Vitafoods Europe 2025 in Barcelona for its natural menopause solution, Lifenol. Recognized for its science-backed botanical innovation, Lifenol is powered by a patented hops extract rich in prenylnaringenin (8-PN), a phytoestrogen known for its effectiveness.

Clinically validated in gold-standard trials, a daily 85 mg dose of Lifenol has been shown to reduce menopausal symptoms like hot flashes and sleep disturbances. It also supports bone mineral density, offering a holistic approach to menopause care.

This award reinforces Givaudan’s leadership in creating natural, effective wellness solutions that improve quality of life. Lifenol stands out as a low-dose, plant-based option backed by strong clinical evidence for managing menopause naturally and effectively.

28-05-2025